相关实验视频
Updated: Jun 13, 2025
11:53
Cecal Ligation Puncture Procedure
Published on: May 7, 2011
54.8K
一把双刃剑:关于在败血症和败血症休克中使用类固醇的叙事评论
Matteo Guarino1,2, Francesco Luppi1, Benedetta Perna1,3
1Department of Translational Medicine, University of Ferrara, Ferrara, Italy.
Internal and emergency medicine
|June 11, 2025
概括
皮质类固醇,如皮质可能稳定出血动力学在败血性休克,但显示最小的长期生存益处. 它们在败血症治疗中的作用仍然不确定,需要进一步研究以获得最佳使用.
科学领域:
- 关键护理医学 关键护理医学
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
背景情况:
- 败血症和败血性休克是严重的疾病,宿主对感染的反应失调.
- 皮质类固醇,特别是皮质,用于血动力稳定性在败血性休克,但他们的有效性是有争议的.
研究的目的:
- 批判性地评估皮质类固醇在治疗败血症休克中的作用.
- 评估皮质类固醇对败血症休克患者死亡率,血液动力学和临床结果的影响.
主要方法:
- 进行了全面的文献搜索,包括随机对照试验,元分析和临床指南.
- 分析了研究,以评估皮质类固醇对各种患者结局的影响.
主要成果:
- 皮质类固醇证明了血液动力稳定性的短期改善,并减少了血管压缩剂的需求.
- 然而,它们对败血症休克的长期生存的影响很小.
- 剂量,时间和患者选择的变化表明缺乏标准化治疗.
结论:
- 目前的指导方针对持续性败血性休克低血压中使用皮的建议很弱.
- 皮质类固醇在感染性休克管理中可能有好处,但它们的确切作用仍然不确定.
- 进一步的研究对于优化治疗方案和为皮质类固醇治疗选择患者至关重要.
相关概念视频
01:24Blood Pressure Imbalances and Circulatory Shock
761
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
761
01:26Heart Failure Drugs: Inotropic Agents
539
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
539